Source link : https://newshealth.biz/health-news/ema-approves-ai-tool-for-mash-clinical-trials/
The European Medicines Agency (EMA) offered a positive opinion last week on a new artificial intelligence (AI)–based tool that supports pathologists in diagnosing and assessing the severity of metabolic dysfunction–associated steatohepatitis (MASH) during clinical trials. This is the first “qualification opinion” by the EMA’s human medicines committee (Committee for Medicinal Products for Human Use [CHMP]) […]
The post EMA Approves AI Tool for MASH Clinical Trials first appeared on News Health.
Author : News Health
Publish date : 2025-03-26 13:03:00
Copyright for syndicated content belongs to the linked Source.